Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.08 USD | -7.71% | -1.80% | +82.27% |
05-14 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
05-13 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+82.27% | 311M | |
+40.72% | 50.93B | |
-0.50% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.61% | 26.02B | |
-21.89% | 18.9B | |
+7.30% | 13.21B | |
+24.45% | 12.17B | |
+30.17% | 12.16B |
- Stock Market
- Equities
- INO Stock
- News Inovio Pharmaceuticals, Inc.
- Transcript : Inovio Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 10, 2022